Patent · US Active

Prodrugs of A2B adenosine receptor antagonists

US8143249B2 · kind B2 · utility

3Cited by
26References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 21, 2011
Grant dateMar 27, 2012
Priority date—
Expiry dateJan 21, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D473/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are prodrugs of A2B adenosine receptor antagonists of the formula:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.